OD

Oommen Daniel

Active Director Director DIN 06814411
DIN 06814411 First appointment Mar 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2014
Shareholding value •••• Premium profile

About Oommen Daniel

Data last updated:

Oommen Daniel is a Director at Providence Medical Specialities And Research Private Limited (since 2014). The company operates in Healthcare. Providence Medical Specialities And Research Private Limited reported revenue of ₹3.30 Cr (FY 2024).

DIN 06814411
Primary Designation Director
Industry Healthcare
First Appointment 28 Mar 2014
Oldest Company Age 12 yrs
Largest company Providence Medical Specialities And Research Private Limited · ₹3.30 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Mar 20142014₹3.30 Cr (FY 2024)Active

Board colleagues of Oommen Daniel

Directorship timeline

Open interactive timeline →
Providence Medical Specialities And Research Private Limited
Premium access

Shareholding and investment profile for Oommen Daniel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Oommen Daniel

Oommen Daniel currently holds 1 directorship: Providence Medical Specialities And Research Private Limited (Director, since 28 Mar 2014, revenue ₹3.30 Cr (FY 2024)).

Oommen Daniel was first appointed on 28 Mar 2014 as Director at Providence Medical Specialities And Research Private Limited.

The current boards of Oommen Daniel's companies include Mathew John (Providence Medical Specialities And Research Private Limited), Tittu Oommen (Providence Medical Specialities And Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available